Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacists' liability into the year 2000

N J Lynn1, J M Ellis

  • 1Health Law Department of Holleb & Coff, Chicago, Ill. 60603-5896, USA. nLynn@holleb-law.com

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|December 23, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Project Sandman: A Quasi-Experimental Evaluation of a Group-Based Brief Sleep Intervention in Air Force Technical Training.

Behavioral sleep medicine·2024
Same author

A social-ecological examination of sleep among Airmen in technical training.

Military psychology : the official journal of the Division of Military Psychology, American Psychological Association·2024
Same author

Studies on imported malarias; transmission of foreign Plasmodium vivax by Anopheles quadrimaculatus.

The American journal of tropical medicine and hygiene·2010
Same author

Effect of forage intake on bodyweight and performance.

Equine veterinary journal. Supplement·2002
Same author

Use of height-specific weigh tapes to estimate the bodyweight of horses.

The Veterinary record·2002
Same author

HLA-B allele frequencies in Côte d'Ivoire defined by direct DNA sequencing: identification of HLA-B*1405, B*4410, and B*5302.

Tissue antigens·2001
Same journal

The Sky is His Wife (2001)/Jim Alford (b. 1943).

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Zada Mary cooper (1875-1961).

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Aiming for, believing in, and achieving a target a1c of less than 7.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Evaluation of OTC Product Information in Three Drug Information Databases for PDAs.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

New biotechnology approvals for 2002.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Preventing meningococcal outbreaks: an opportunity for pharmacists.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
See all related articles

Pharmacists face increasing liability risks due to evolving healthcare roles and patient counseling laws. Courts may extend the duty to warn for prescription drug issues, impacting pharmacy practice.

Area of Science:

  • Pharmacy Law
  • Healthcare Liability
  • Professional Responsibility

Background:

  • The pharmacist's role in healthcare delivery is expanding.
  • Increased public and media scrutiny impacts pharmacy practice.
  • Evolving legal landscape presents new challenges for pharmacists.

Purpose of the Study:

  • To inform the pharmacy community about potential legal liabilities.
  • To highlight areas of risk in the changing healthcare system.
  • To educate on the expanding duty of care for pharmacists.

Main Methods:

  • Review of published legal cases (LEXIS, Westlaw).
  • Analysis of relevant literature (NEXIS, Westlaw).
  • Selection of cases based on relevance to practicing pharmacists.

Related Experiment Videos

Main Results:

  • Pharmacists' liability exposure is increasing with their evolving roles.
  • New laws mandate patient counseling, raising potential for litigation.
  • Courts are extending the "duty to warn" in specific scenarios, including special patient knowledge and dosage concerns.
  • Generic substitution of narrow therapeutic index drugs presents new liability risks.

Conclusions:

  • The expanding role of pharmacists and public scrutiny will likely increase the "duty to warn."
  • Pharmacists must be aware of potential liabilities related to prescription drug products.
  • This trend of increased pharmacist liability is expected to continue.